Diagnosing Lung Cancer

This information is useful for adults and older adults
Why Yale Medicine?
  • A multidisciplinary group of experts gathers at a weekly conference to discuss cases, which provides patients the benefit of many expert opinions.
  • Pathologists at Yale Medicine are highly specialized.
  • Our pathologists have unparalleled experience in the diagnosis of lung cancer in the region.

Lung cancer, one of the most common cancers in the world, is a leading cause of cancer-related death in men and women in the United States. Smoking cigarettes is usually the cause of lung cancer, but far from the only one. Risk factors also include exposure to asbestos, radiation and pollution, or a family history of the condition. Non-small cell lung cancers account for about 80 percent to 85 percent of lung cancer and small cell lung cancer makes up about 10 percent to 15 percent.

Yale Medicine's pathologists at are highly specialized—some specialize in bone and soft tissue pathology, related to the ribs, sternum and vertebral column, as well as hematologic conditions involving white cells that can form masses, particularly in the lymph nodes in the middle of the chest.

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.